Teladoc Health, Inc. officer Carlos Nueno filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 29,432 shares of Teladoc Health common stock with an aggregate market value of $270,774.40.

Key Highlights

  • Proposed sale: 29,432 shares of Teladoc Health common stock with an aggregate market value of $270,774.40.
  • Seller: Carlos Nueno, identified as an officer of Teladoc Health, Inc. (NYSE:TDOC).
  • Broker: Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield, RI 02917, named as the executing broker.
  • Shares outstanding: 182,293,675 shares of common stock outstanding at the time of filing.
  • Source of shares: All shares proposed for sale were acquired through restricted stock vesting from the issuer across five vesting dates between March 1, 2025 and September 1, 2026, as compensation.
  • Rule 10b5-1 plan: The filing indicates a trading plan or instruction date of August 4, 2026.
  • Prior sales: Carlos Nueno Plana sold 6,200 shares on September 2, 2026, with gross proceeds of $39,068.06, within the three months preceding this filing.

Teladoc Officer Nueno Discloses Proposed Common Stock Sale Under Rule 144

According to the Form 144 filing submitted to the U.S. Securities and Exchange Commission on November 6, 2026, Carlos Nueno, an officer of Teladoc Health, Inc., proposed to sell 29,432 shares of the company's common stock through Fidelity Brokerage Services LLC. The aggregate market value of the shares to be sold was listed as $270,774.40. The approximate date of sale noted in the filing is November 6, 2026, on the NYSE.

The filing discloses that the shares were acquired entirely through restricted stock vesting from the issuer, classified as compensation. Five separate vesting transactions are listed: 2,932 shares on March 1, 2025; 9,959 shares on March 19, 2025; 4,754 shares on June 1, 2025; 4,714 shares on September 1, 2025; and 7,073 shares on September 1, 2026. Each vesting event is described as a "Restricted Stock Vesting" transaction in which the issuer is named as the person from whom the shares were acquired, with payment described as compensation.

The filing also reports that within the three months preceding the notice, Carlos Nueno Plana sold 6,200 shares of Teladoc Health common stock on September 2, 2026, generating gross proceeds of $39,068.06. The notice further states that the sale is being made pursuant to a Rule 10b5-1 trading plan or instruction adopted on August 4, 2026. The filing was signed by Daniel Tucci as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Carlos Nueno Plana.

What Was Disclosed

Teladoc Health officer Carlos Nueno filed a Form 144 notice proposing the sale of 29,432 shares of common stock valued at $270,774.40, acquired through restricted stock vesting as compensation, with a Rule 10b5-1 plan dated August 4, 2026.